Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margalida Rotger

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Chimia|August 8, 2012
Dosage optimization of treatments using population pharmacokinetic modeling and simulationM Guidi, Mona Arab-Alameddine, Margalida Rotger, et al.
Pharmacogenetics and Genomics|December 20, 2012
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing studyMaria Dobrinas, Séverine Crettol, Beatrice Oneda, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected IndividualsManel Aouri, Catalina Barcelo, Monia Guidi, et al.
Pharmacogenetics and Genomics|July 26, 2005
Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivoSara Colombo, Nicole Soranzo, Margalida Rotger, et al.
Pharmacogenetics and Genomics|May 3, 2005
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patientsMargalida Rotger, Sara Colombo, Hansjakob Furrer, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individualsCatalina Barceló, Frédéric Gaspar, Manel Aouri, et al.
The Journal of Infectious Diseases|September 20, 2005
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemiaMargalida Rotger, Patrick Taffe, Gabriela Bleiber, et al.
Antiviral Therapy|July 18, 2014
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestryMonia Guidi, Giuseppe Foletti, Paul McLaren, et al.
The Journal of Infectious Diseases|August 8, 2008
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavirSara Colombo, Andri Rauch, Margalida Rotger, et al.
Plos One|July 29, 2015
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort StudyHelen Kovari, Stefan Russmann, Bruno Ledergerber, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Chimia|August 8, 2012
Dosage optimization of treatments using population pharmacokinetic modeling and simulationM Guidi, Mona Arab-Alameddine, Margalida Rotger, et al.
Pharmacogenetics and Genomics|December 20, 2012
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing studyMaria Dobrinas, Séverine Crettol, Beatrice Oneda, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected IndividualsManel Aouri, Catalina Barcelo, Monia Guidi, et al.
Pharmacogenetics and Genomics|July 26, 2005
Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivoSara Colombo, Nicole Soranzo, Margalida Rotger, et al.
Pharmacogenetics and Genomics|May 3, 2005
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patientsMargalida Rotger, Sara Colombo, Hansjakob Furrer, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individualsCatalina Barceló, Frédéric Gaspar, Manel Aouri, et al.
The Journal of Infectious Diseases|September 20, 2005
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemiaMargalida Rotger, Patrick Taffe, Gabriela Bleiber, et al.
Antiviral Therapy|July 18, 2014
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestryMonia Guidi, Giuseppe Foletti, Paul McLaren, et al.
The Journal of Infectious Diseases|August 8, 2008
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavirSara Colombo, Andri Rauch, Margalida Rotger, et al.
Plos One|July 29, 2015
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort StudyHelen Kovari, Stefan Russmann, Bruno Ledergerber, et al.
Pageof 5